openPR Logo
Press release

Bronchiectasis Therapeutics Analysis - Clinical Trials & Results, Collaboration and Developments

09-12-2018 06:07 AM CET | Health & Medicine

Press release from: P&S Intelligence - Pharmaceuticals

Bronchiectasis Therapeutics Analysis - Clinical Trials &

The study analysed that the Bronchiectasis therapeutics pipeline comprises approximately 13 drug candidates in different stages of development. Bronchiectasis is a condition in which damage to the airways causes them to widen and become flabby and scarred. The airways are tubes that carry air in and out of lungs. Bronchiectasis usually is the result of an infection or other condition that injures the walls of airways or prevents the airways from clearing mucus. In bronchiectasis, the airways slowly lose their ability to clear out mucus. When mucus cannot be cleared, it builds up and creates an environment in which bacteria can grow. This leads to frequent and serious lung infections.

Explore report sample at: https://www.psmarketresearch.com/market-analysis/bronchiectasis-therapeutics-pipeline-analysis/report-sample

The research also found that there are several companies that use synthetic sources for the development of drugs for the treatment of bronchiectasis.

Some of the other key players developing drugs for the treatment of bronchiectasis include Aradigm Corporation, Bayer AG, Zambon SpA and others.

Browse report at: https://www.psmarketresearch.com/market-analysis/bronchiectasis-therapeutics-pipeline-analysis

Bronchiectasis Pipeline Analysis
• By Phase
• By Molecule Type
• By Route of Administration
• By Company

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bronchiectasis Therapeutics Analysis - Clinical Trials & Results, Collaboration and Developments here

News-ID: 1234442 • Views: 230

More Releases from P&S Intelligence - Pharmaceuticals

Cyclin-Dependent Kinase Inhibitors Therapeutics Key Players Analysis - Merck, El …
The study analyzed that the CDK inhibitors therapeutics pipeline comprises approximately 24 drug candidates in different stages of development. CDKs are the catalytic subunits of serine or threonine protein kinases that regulate the checkpoints in the cell cycle to control the proliferative capacity of cancerous cells. These proteins form cyclin-CDK complex which gets activated after phosphorylation, leading to cell proliferation. Download report sample at: http://bit.ly/2eqiPu5 **Various collaborations for CDK inhibitors drug development Eli Lilly
Systemic Lupus Erythematosus Pipeline Analysis - Anthera Pharmaceuticals, Inc., …
The study analyzed that the systemic lupus erythematosus pipeline comprises of 57 drug candidates in different stages of development. Explore report sample at: https://www.psmarketresearch.com/market-analysis/systemic-lupus-erythematosus-pipeline-analysis/report-sample Systemic lupus erythematosus is a type of lupus in which the immune system damages its own tissues. The disease affects many parts of the body including skin, joints, lungs, brain, blood vessels and kidneys. The systemic lupus erythematosus is caused by impaired immune system due to which the
Herpes Simplex Virus Infections Therapeutic - Pipeline Analysis, Clinical Trials …
The study analysed that the Herpes simplex virus infections pipeline comprises of 20 drug candidates in different stages of development. As per the findings of the research, most of the drug candidates are being developed to be administered by oral route. Explore report sample at: https://www.psmarketresearch.com/market-analysis/hsv-infections-therapeutics-pipeline-analysis/report-sample Many technologies are being developed that offer promising innovative treatments which can control the progression of Herpes simplex virus infections. The technologies include, but not limited to,
Japanese Encephalitis Therapeutics - Pipeline Analysis, Clinical Trials, Patent …
Japanese encephalitis is a viral infection that spreads by mosquito bites. The study analyzed that the Japanese encephalitis therapeutics pipeline comprises approximately 12 drug candidates in different stages of development. Explore report sample at: https://www.psmarketresearch.com/market-analysis/japanese-encephalitis-therapeutics-pipeline/report-sample The companies developing drugs for the treatment of Japanese encephalitis are laying more emphasis on the drug candidates to be developed as vaccines, due to the promising results shown by these candidates the in the clinical development.

All 5 Releases


More Releases for Bronchiectasis

Bronchiectasis Global Market Research Report 2025
Bronchiectasis Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/bronchiectasis-market/80987 The report firstly introduced the Bronchiectasis basics: definitions, classifications, applications and market overview; product
Bronchiectasis - Market Insights, Epidemiology and Market Forecast 2018-2027
Bronchiectasis Market: WiseGuyReports.com adds “Bronchiectasis Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting 2027” reports tits database. Executive Summary “Bronchiectasis - Market Insights, Epidemiology and Market Forecast – 2027” report provides the detailed overview of the disease and in depth understanding of historical and forecasted epidemiology. It highlights the existing treatment patterns, potential upcoming drugs and also identifies best of the market opportunities by providing the current and forecasted market
Global Bronchiectasis Treatment Market Review 2018-2023 Insmed, Bayer, Recipharm
A market study "Global Bronchiectasis Treatment Market" examines the performance of the Bronchiectasis Treatment market 2018. It encloses an in-depth Research of the Bronchiectasis Treatment market state and the competitive landscape globally. This report analyzes the potential of Bronchiectasis Treatment market in the present and the future prospects from various angles in detail. The Global Bronchiectasis Treatment Market 2018 report includes Bronchiectasis Treatment market Revenue, market Share, Bronchiectasis Treatment industry volume,
Bronchiectasis Treatment Market Trends Detailed in New Research Report 2025
Bronchiectasis refers to a condition characterized by damaged airways (tubes) and affect their ability to clear out the mucus. This deposition of mucus leads to bacterial infections and hence resulting in serious and repeated lung infections. Bronchiectasis is a long term condition resulting in serious health conditions such as heart failure and respiratory failure. Mucus producing cough is the major symptom of this condition. Request Report for Table of Contents
Bronchiectasis Therapeutics Clinical Trials, Pipeline Analysis & Collaboration
Bronchiectasis is a condition in which damage to the airways causes them to widen and become flabby and scarred. The airways are tubes that carry air in and out of lungs. Bronchiectasis usually is the result of an infection or other condition that injures the walls of airways or prevents the airways from clearing mucus. In bronchiectasis, the airways slowly lose their ability to clear out mucus. When mucus cannot
Bronchiectasis Market Globally Expected to Drive Growth by 2025
Bronchiectasis is a chronic and life-threatening disease, wherein parts of airways of lungs are permanently enlarged. This condition damages the bronchial tubes of lungs permanently and also widens, and thickens them. Inflammation and infection in the bronchi leads to this condition. The severity of bronchiectasis symptoms may vary widely. The most common symptom of bronchiectasis is breathlessness i.e., difficulty in breathing or feeling short of breath, frequent chest infections, and